Please sign in to follow a disease.
Compass Therapeutics
Clinical trials sponsored by Compass Therapeutics, explained in plain language.
COMPASS Therapeutics is a biopharmaceutical company developing psychedelic-based therapies for mental health.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New experimental drug CTX-8371 enters first human tests for tough cancers Results expected Dec 2026 (estimated)
- New combo therapy shows promise for Tough-to-Treat bile duct cancer Results expected Aug 2027 (estimated) May already have reported ↗ 🚀 Make-or-break